#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4420082	Functional	Growth inhibition of human UM-SCC-1 cells assessed as decrease in cell number at 0.01 uM incubated for 72 hrs by MTS assay relative to control	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data
2.	ALA4420083	Functional	Growth inhibition of human UM-SCC-1 cells assessed as decrease in cell number at 0.1 uM incubated for 24 hrs by MTT assay relative to control	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data
3.	ALA4420084	Functional	Growth inhibition of human UM-SCC-1 cells assessed as decrease in cell number at 0.1 uM incubated for 48 hrs by MTT assay relative to control	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data
4.	ALA4420085	Functional	Growth inhibition of human UM-SCC-1 cells assessed as decrease in cell number at 0.1 uM incubated for 72 hrs by MTT assay relative to control	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data
5.	ALA4420086	Functional	Growth inhibition of human UM-SCC-1 cells assessed as decrease in cell number at 0.1 uM incubated for 96 hrs by MTT assay relative to control	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data
6.	ALA4420087	Functional	Growth inhibition of human UM-SCC-1 cells assessed as decrease in cell number at 0.01 uM incubated for 72 hrs by MTT assay relative to control	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data
7.	ALA4420088	Functional	Growth inhibition of human UM-SCC-1 cells assessed as decrease in cell number at 0.01 uM incubated for 96 hrs by MTT assay relative to control	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data
8.	ALA4420089	Functional	Growth inhibition of human UM-SCC-1 cells assessed as decrease in cell number at 0.1 uM incubated for 24 hrs in presence of 1 uM OGF by MTT assay relative to control	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data
9.	ALA4420090	Functional	Growth inhibition of human UM-SCC-1 cells assessed as decrease in cell number at 0.1 uM incubated for 48 hrs in presence of 1 uM OGF by MTT assay relative to control	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data
10.	ALA4420091	Functional	Growth inhibition of human UM-SCC-1 cells assessed as decrease in cell number at 0.1 uM incubated for 72 hrs in presence of 1 uM OGF by MTT assay relative to control	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data
11.	ALA4420092	Functional	Growth inhibition of human UM-SCC-1 cells assessed as decrease in cell number at 0.1 uM incubated for 96 hrs in presence of 1 uM OGF by MTT assay relative to control	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data
12.	ALA4420093	Functional	Growth inhibition of human UM-SCC-1 cells assessed as decrease in cell number at 0.01 uM incubated for 48 hrs in presence of 1 uM OGF by MTT assay relative to control	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data
13.	ALA4420094	Functional	Growth inhibition of human UM-SCC-1 cells assessed as decrease in cell number at 0.01 uM incubated for 72 hrs in presence of 1 uM OGF by MTT assay relative to control	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data
14.	ALA4420095	Functional	Growth inhibition of human UM-SCC-1 cells assessed as decrease in cell number at 0.01 uM incubated for 96 hrs in presence of 1 uM OGF by MTT assay relative to control	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data
15.	ALA4420098	Functional	Antitumor activity against human UM-SCC-1 cells xenografted in nu/nu mouse assessed as mouse mortality at 8 mg/kg dosed every other day measured on day 19 relative to control	Homo sapiens	1	ALA4420060	organism-based format	Patent Bioactivity Data
16.	ALA4420099	Functional	Antitumor activity against human UM-SCC-1 cells xenografted in nu/nu mouse assessed as mouse mortality at 8 mg/kg dosed every other day measured on day 40 relative to control	Homo sapiens	1	ALA4420060	organism-based format	Patent Bioactivity Data
17.	ALA4420100	Functional	Antitumor activity against human UM-SCC-1 cells xenografted in nu/nu mouse assessed as mouse mortality at 8 mg/kg dosed every other day measured on day 40 co-treated with 10 mg/kg/day OGF relative to control	Homo sapiens	1	ALA4420060	organism-based format	Patent Bioactivity Data
18.	ALA4420101	Functional	Antitumor activity against human UM-SCC-1 cells xenografted in nu/nu mouse assessed as mouse mortality at 8 mg/kg dosed every other day measured on day of study termination relative to control	Homo sapiens	1	ALA4420060	organism-based format	Patent Bioactivity Data
19.	ALA4420105	Functional	Antitumor activity against human UM-SCC-1 cells xenografted in nu/nu mouse assessed as tumor incidence at 8 mg/kg dosed every other day and measured on day 13 after tumor cell inoculation	Homo sapiens	1	ALA4420060	organism-based format	Patent Bioactivity Data
20.	ALA4420106	Functional	Antitumor activity against human UM-SCC-1 cells xenografted in nu/nu mouse assessed as tumor incidence co-treated with OGF measured on day 13 after tumor cell inoculation	Homo sapiens	1	ALA4420060	cell-based format	Patent Bioactivity Data